John Wiley & Sons

SHERPA: Green

People

  1. Zelenetz
    Zelenetz
  2. Yahalom
    Yahalom
  3. Zhang
    Zhang
  4. Hamlin
    Hamlin
  5. Horwitz
    Horwitz
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Sarasohn
    Sarasohn
  9. Castro-Malaspina
    Castro-Malaspina
  10. Perales
    Perales

Groups

  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (16)
  4. Lymphoma (15)
  5. Survivorship Research (9)
  6. Biostatistics Service (8)
  7. Epidemiology and Biostatistics (8)
  8. Radiation Oncology, Department of (7)
  9. Nursing (6)
  10. Population Sciences Research Program (6)
Search Within
  1. "Craig Moskowitz"
Formats
  1. Journal Article (18)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (16)
  4. Lymphoma (15)
  5. Survivorship Research (9)
  6. Biostatistics Service (8)

More Groups

People
  1. Craig Moskowitz (18)
  2. Andrew Zelenetz (13)
  3. Carol Portlock (7)
  4. David Straus (7)
  5. Joachim Yahalom (7)
  6. Paul Hamlin (7)

More People

Years
  1. 2017 (1)
  2. 2016 (3)
  3. 2015 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (3)

More Years

Publications
  1. British Journal of Haematology (17)
  2. Psycho-Oncology (1)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Journal Article

    Vardhana, S. A.; Sauter, C. S.; Matasar, M. J.; Zelenetz, A. D.; Galasso, N.; Woo, K. M.; Zhang, Z.; Moskowitz, C. H.
    British Journal of Haematology (2017)

    Fulltext@MSK | Save
  • Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma
    Journal Article

    Ramsey, S. D.; Nademanee, A.; Masszi, T.; Holowiecki, J.; Abidi, M.; Chen, A.; Stiff, P.; Viviani, S.; Sweetenham, J. W.; Radford, J.; more...
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Journal Article

    Shah, G. L.; Yahalom, J.; Matasar, M. J.; Verwys, S. L.; Goldman, D. A.; Bantilan, K. S.; Zhang, Z.; McCall, S. J.; Moskowitz, A. J.; Moskowitz, C. H.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months
    Journal Article

    Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Kumar, A.; Lunning, M. A.; Zhang, Z.; Migliacci, J. C.; Moskowitz, C. H.; Zelenetz, A. D.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: Results from two transplant centres
    Journal Article

    Smith, S. D.; Moskowitz, C. H.; Dean, R.; Pohlman, B.; Sobecks, R.; Copelan, E.; Andresen, S.; Bolwell, B.; Maragulia, J. C.; Vanak, J. M.; more...
    British Journal of Haematology (2011)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial
    Journal Article

    O'Connor, O. A.; Moskowitz, C.; Portlock, C.; Hamlin, P.; Straus, D.; Dumitrescu, O.; Sarasohn, D.; Gonen, M.; Butos, J.; Neylon, E.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Perales, M. A.; Kewalramani, T.; Yahalom, J.; Castro-Malaspina, H.; Zhang, Z.; Vanak, J.; Zelenetz, A. D.; Moskowitz, C. H.
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma
    Journal Article

    Gerecitano, J.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Zelenetz, A. D.; Zhang, Z.; Dumitrescu, O.; Sarasohn, D.; Lin, D.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save